Evidence map›Paper›PMID 38495874›Full record

ReviewFrontiers in immunology2024

Asymmetric T-cell division: insights from cutting-edge experimental techniques and implications for immunotherapy.

Yaroslav Kaminskiy, Irina Ganeeva, Vitaly Chasov, Anna Kudriaeva, Emil Bulatov

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Yaroslav KaminskiyDepartment of Oncology and Pathology, Karolinska Institutet, SciLifeLab, Solna, Sweden.
Irina GaneevaInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
Vitaly ChasovInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
Anna KudriaevaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Emil BulatovInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
Institute of Bioorganic Chemistry · RUKazan Federal University · RUKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asymmetric cell division is a fundamental process conserved throughout evolution, employed by both prokaryotic and eukaryotic organisms. Its significance lies in its ability to govern cell fate and facilitate the generation of diverse cell types. Therefore, attaining a detailed mechanistic understanding of asymmetric cell division becomes essential for unraveling the complexities of cell fate determination in both healthy and pathological conditions. However, the role of asymmetric division in T-cell biology has only recently been unveiled. Here, we provide an overview of the T-cell asymmetric division field with the particular emphasis on experimental methods and models with the aim to guide the researchers in the selection of appropriate

Indexed as

Asymmetric Cell DivisionEpigenesis, GeneticCell DifferentiationImmunotherapyT-Lymphocyte Subsetsasymmetric division (AD)immunotherapyT cellT cell divisionT cell fate

Identifiers

PMID38495874
PMCPMC10940324
OpenAlexW4392365099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.